BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McDermott JH, Burn J, Donnai D, Newman WG. The rise of point-of-care genetics: how the SARS-CoV-2 pandemic will accelerate adoption of genetic testing in the acute setting. Eur J Hum Genet 2021;29:891-3. [PMID: 33589764 DOI: 10.1038/s41431-021-00816-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Mahas A, Wang Q, Marsic T, Mahfouz MM. A Novel Miniature CRISPR-Cas13 System for SARS-CoV-2 Diagnostics. ACS Synth Biol 2021;10:2541-51. [PMID: 34546709 DOI: 10.1021/acssynbio.1c00181] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 McNeill A. Clinical genomics-but faster. Eur J Hum Genet 2021;29:889-90. [PMID: 34006928 DOI: 10.1038/s41431-021-00906-w] [Reference Citation Analysis]
3 Campos-Ferreira D, Visani V, Córdula C, Nascimento GA, Montenegro LML, Schindler HC, Cavalcanti IMF. COVID-19 challenges: From SARS-CoV-2 infection to effective point-of-care diagnosis by electrochemical biosensing platforms. Biochem Eng J 2021;176:108200. [PMID: 34522158 DOI: 10.1016/j.bej.2021.108200] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chu H, Liu C, Liu J, Yang J, Li Y, Zhang X. Recent advances and challenges of biosensing in point-of-care molecular diagnosis. Sens Actuators B Chem 2021;348:130708. [PMID: 34511726 DOI: 10.1016/j.snb.2021.130708] [Reference Citation Analysis]
5 Harpaldas H, Arumugam S, Campillo Rodriguez C, Kumar BA, Shi V, Sia SK. Point-of-care diagnostics: recent developments in a pandemic age. Lab Chip 2021;21:4517-48. [PMID: 34778896 DOI: 10.1039/d1lc00627d] [Reference Citation Analysis]